SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ACCELRYS
(NQNM:ACCL Last Sale: 9.16 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ACCL : $9.16)
$251 million Market Cap at September 12, 2013
Employs 365.
Software & Services SubIndustry up .00% / Technology Industry up .00% Today
10188 Telesis Court Research Report Earnings Snapshot - Last 02/25/18
San Diego, CA 92121 Fact Sheet
Phone: (858) 799-5000 Financial Statements
Peer Comparison
Annual Reports

Scipio (Max) Carnecchia, Pres./CEO, Rick Russo, CFO
Develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Initial focus was as a provider of computational tools to support drug discovery. Developed and commercialized molecular modeling and simulation software for the life sciences and materials research markets, cheminformatics and decision support systems, and bioinformatics tools including gene sequence analysis. Spun-off drug discovery business, 1-for-2, April 30, 2004, under the PHARMACOPEIA name, then changed name to ACCELRYS INC., and moved to San Diego. Acquired Molecular Simulations Inc. in 1998.
Historical Charts    Technical Analysis
No Historical Data available for ACCL

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ACCL $9.16 $ 0 $9.15 $9.35 97,783 $7.75 $9.98 27,424
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $251,204

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
01-MAR-04 PCOP Symbol Changed to ACCL

A276
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex